Article
Prodrug-activated gene therapy: involvement of an immunological component in the "bystander effect".
Cancer gene therapy - 1 Jan 2000
Gagandeep S, Brew R, Green B, Christmas S E, Klatzmann D, Poston G J, Kinsella A R
Abstract excerpt
The integration and expression of the herpes simplex virus type 1 thymidine kinase (HSV1-TK) gene in localized tumors results in tumor regression after the administration of the specific nucleoside analogue ganciclovir (GCV). Although only 10% to 20% of the tumor cells take up the HSV1-TK gene, the neighboring cells also die, a phenomenon termed "bystander effect.". In the present study, coinjection of the MC26...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
